SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'TCL'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_A_BEZA349_0 (D-AMINO ACID OXIDASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 5 | TYR A 267TYR A 277ILE A 323GLY A 313 | TCL A 802 (-3.6A)TCL A 802 (-4.4A)NoneNAD A 801 (-4.8A) | 0.99A | 1kifA-3am3A:4.4 | 1kifA-3am3A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_A_BEZA349_0 (D-AMINO ACID OXIDASE) |
3f4b | ENOYL-ACYL CARRIERPROTEIN REDUCTASE (Plasmodiumberghei) | 4 / 5 | TYR A 252TYR A 262ILE A 308GLY A 298 | TCL A 400 (-3.6A)TCL A 400 (-4.7A)NoneNAD A 450 (-4.9A) | 1.09A | 1kifA-3f4bA:3.8 | 1kifA-3f4bA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_B_BEZB349_0 (D-AMINO ACID OXIDASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 5 | TYR A 267TYR A 277ILE A 323GLY A 313 | TCL A 802 (-3.6A)TCL A 802 (-4.4A)NoneNAD A 801 (-4.8A) | 0.99A | 1kifB-3am3A:4.4 | 1kifB-3am3A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_B_BEZB349_0 (D-AMINO ACID OXIDASE) |
3f4b | ENOYL-ACYL CARRIERPROTEIN REDUCTASE (Plasmodiumberghei) | 4 / 5 | TYR A 252TYR A 262ILE A 308GLY A 298 | TCL A 400 (-3.6A)TCL A 400 (-4.7A)NoneNAD A 450 (-4.9A) | 1.09A | 1kifB-3f4bA:3.9 | 1kifB-3f4bA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_C_BEZC349_0 (D-AMINO ACID OXIDASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 5 | TYR A 267TYR A 277ILE A 323GLY A 313 | TCL A 802 (-3.6A)TCL A 802 (-4.4A)NoneNAD A 801 (-4.8A) | 0.99A | 1kifC-3am3A:4.4 | 1kifC-3am3A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_C_BEZC349_0 (D-AMINO ACID OXIDASE) |
3f4b | ENOYL-ACYL CARRIERPROTEIN REDUCTASE (Plasmodiumberghei) | 4 / 5 | TYR A 252TYR A 262ILE A 308GLY A 298 | TCL A 400 (-3.6A)TCL A 400 (-4.7A)NoneNAD A 450 (-4.9A) | 1.09A | 1kifC-3f4bA:3.8 | 1kifC-3f4bA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_D_BEZD349_0 (D-AMINO ACID OXIDASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 5 | TYR A 267TYR A 277ILE A 323GLY A 313 | TCL A 802 (-3.6A)TCL A 802 (-4.4A)NoneNAD A 801 (-4.8A) | 0.99A | 1kifD-3am3A:4.4 | 1kifD-3am3A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_D_BEZD349_0 (D-AMINO ACID OXIDASE) |
3f4b | ENOYL-ACYL CARRIERPROTEIN REDUCTASE (Plasmodiumberghei) | 4 / 5 | TYR A 252TYR A 262ILE A 308GLY A 298 | TCL A 400 (-3.6A)TCL A 400 (-4.7A)NoneNAD A 450 (-4.9A) | 1.09A | 1kifD-3f4bA:4.4 | 1kifD-3f4bA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_E_BEZE349_0 (D-AMINO ACID OXIDASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 5 | TYR A 267TYR A 277ILE A 323GLY A 313 | TCL A 802 (-3.6A)TCL A 802 (-4.4A)NoneNAD A 801 (-4.8A) | 0.99A | 1kifE-3am3A:4.4 | 1kifE-3am3A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_E_BEZE349_0 (D-AMINO ACID OXIDASE) |
3f4b | ENOYL-ACYL CARRIERPROTEIN REDUCTASE (Plasmodiumberghei) | 4 / 5 | TYR A 252TYR A 262ILE A 308GLY A 298 | TCL A 400 (-3.6A)TCL A 400 (-4.7A)NoneNAD A 450 (-4.9A) | 1.09A | 1kifE-3f4bA:3.9 | 1kifE-3f4bA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_F_BEZF349_0 (D-AMINO ACID OXIDASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 5 | TYR A 267TYR A 277ILE A 323GLY A 313 | TCL A 802 (-3.6A)TCL A 802 (-4.4A)NoneNAD A 801 (-4.8A) | 0.99A | 1kifF-3am3A:4.5 | 1kifF-3am3A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_F_BEZF349_0 (D-AMINO ACID OXIDASE) |
3f4b | ENOYL-ACYL CARRIERPROTEIN REDUCTASE (Plasmodiumberghei) | 4 / 5 | TYR A 252TYR A 262ILE A 308GLY A 298 | TCL A 400 (-3.6A)TCL A 400 (-4.7A)NoneNAD A 450 (-4.9A) | 1.09A | 1kifF-3f4bA:3.8 | 1kifF-3f4bA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_G_BEZG349_0 (D-AMINO ACID OXIDASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 5 | TYR A 267TYR A 277ILE A 323GLY A 313 | TCL A 802 (-3.6A)TCL A 802 (-4.4A)NoneNAD A 801 (-4.8A) | 0.99A | 1kifG-3am3A:4.5 | 1kifG-3am3A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_G_BEZG349_0 (D-AMINO ACID OXIDASE) |
3f4b | ENOYL-ACYL CARRIERPROTEIN REDUCTASE (Plasmodiumberghei) | 4 / 5 | TYR A 252TYR A 262ILE A 308GLY A 298 | TCL A 400 (-3.6A)TCL A 400 (-4.7A)NoneNAD A 450 (-4.9A) | 1.09A | 1kifG-3f4bA:3.9 | 1kifG-3f4bA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_H_BEZH349_0 (D-AMINO ACID OXIDASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 5 | TYR A 267TYR A 277ILE A 323GLY A 313 | TCL A 802 (-3.6A)TCL A 802 (-4.4A)NoneNAD A 801 (-4.8A) | 0.99A | 1kifH-3am3A:4.4 | 1kifH-3am3A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIF_H_BEZH349_0 (D-AMINO ACID OXIDASE) |
3f4b | ENOYL-ACYL CARRIERPROTEIN REDUCTASE (Plasmodiumberghei) | 4 / 5 | TYR A 252TYR A 262ILE A 308GLY A 298 | TCL A 400 (-3.6A)TCL A 400 (-4.7A)NoneNAD A 450 (-4.9A) | 1.09A | 1kifH-3f4bA:4.5 | 1kifH-3f4bA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VE9_A_BEZA352_0 (D-AMINO ACID OXIDASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 5 | TYR A 267TYR A 277ILE A 323GLY A 313 | TCL A 802 (-3.6A)TCL A 802 (-4.4A)NoneNAD A 801 (-4.8A) | 1.01A | 1ve9A-3am3A:4.4 | 1ve9A-3am3A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VE9_A_BEZA352_0 (D-AMINO ACID OXIDASE) |
3f4b | ENOYL-ACYL CARRIERPROTEIN REDUCTASE (Plasmodiumberghei) | 4 / 5 | TYR A 252TYR A 262ILE A 308GLY A 298 | TCL A 400 (-3.6A)TCL A 400 (-4.7A)NoneNAD A 450 (-4.9A) | 1.12A | 1ve9A-3f4bA:4.5 | 1ve9A-3f4bA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1X8V_A_ESLA471_1 (CYTOCHROME P450 51) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 8 | TYR A 277PHE A 368ALA A 319MET A 372 | TCL A 802 (-4.4A)TCL A 802 (-4.8A)TCL A 802 ( 3.3A)None | 1.08A | 1x8vA-3am3A:undetectable | 1x8vA-3am3A:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DU8_G_BEZG2352_0 (D-AMINO-ACID OXIDASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 5 | TYR A 267TYR A 277ILE A 323GLY A 313 | TCL A 802 (-3.6A)TCL A 802 (-4.4A)NoneNAD A 801 (-4.8A) | 1.03A | 2du8G-3am3A:4.5 | 2du8G-3am3A:18.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DU8_G_BEZG2352_0 (D-AMINO-ACID OXIDASE) |
3f4b | ENOYL-ACYL CARRIERPROTEIN REDUCTASE (Plasmodiumberghei) | 4 / 5 | TYR A 252TYR A 262ILE A 308GLY A 298 | TCL A 400 (-3.6A)TCL A 400 (-4.7A)NoneNAD A 450 (-4.9A) | 1.11A | 2du8G-3f4bA:4.5 | 2du8G-3f4bA:20.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DU8_J_BEZJ3352_0 (D-AMINO-ACID OXIDASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 5 | TYR A 267TYR A 277ILE A 323GLY A 313 | TCL A 802 (-3.6A)TCL A 802 (-4.4A)NoneNAD A 801 (-4.8A) | 1.04A | 2du8J-3am3A:4.4 | 2du8J-3am3A:18.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DU8_J_BEZJ3352_0 (D-AMINO-ACID OXIDASE) |
3f4b | ENOYL-ACYL CARRIERPROTEIN REDUCTASE (Plasmodiumberghei) | 4 / 5 | TYR A 252TYR A 262ILE A 308GLY A 298 | TCL A 400 (-3.6A)TCL A 400 (-4.7A)NoneNAD A 450 (-4.9A) | 1.12A | 2du8J-3f4bA:4.4 | 2du8J-3f4bA:20.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
3p9t | REPRESSOR (Stenotrophomonasmaltophilia) | 4 / 6 | LEU A 74MET A 110MET A 113LEU A 174 | NoneTCL A 221 ( 3.4A)TCL A 222 ( 4.7A)None | 1.38A | 2oz7A-3p9tA:undetectable | 2oz7A-3p9tA:19.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T01_A_PPFA503_1 (PHOSPHONOACETATEHYDROLASE) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 4 / 7 | PHE A 368THR A 367ASN A 324ILE A 323 | TCL A 802 (-4.8A)NoneNoneNone | 0.97A | 3t01A-3am3A:undetectable | 3t01A-3am3A:19.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BKL_G_EU7G101_0 (MATRIX PROTEIN 2) |
3am3 | ENOYL-ACP REDUCTASE (Plasmodiumfalciparum) | 5 / 9 | ALA A 284ALA A 219GLY A 280GLY A 233SER A 239 | NoneTCL A 802 (-3.8A)NoneNoneNone | 1.21A | 6bklE-3am3A:undetectable6bklF-3am3A:undetectable6bklG-3am3A:undetectable6bklH-3am3A:undetectable | 6bklE-3am3A:3.956bklF-3am3A:3.956bklG-3am3A:3.956bklH-3am3A:3.95 |